Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?

Lubezky N, Ben-Haim M, Lahat G, Marmor S, Solar I, Brazowski E, Nackache R, Klausner JM.

Surgery. 2012 Jan;151(1):70-5. doi: 10.1016/j.surg.2011.06.036. Epub 2011 Oct 5.

PMID:
21975290
2.

Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.

Yoon WJ, Ryu JK, Lee JK, Woo SM, Lee SH, Park JK, Kim YT, Yoon YB.

Ann Surg Oncol. 2008 Nov;15(11):3193-8. doi: 10.1245/s10434-008-0143-4. Epub 2008 Sep 11.

PMID:
18784959
3.

High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms.

Choi MG, Kim SW, Han SS, Jang JY, Park YH.

Arch Surg. 2006 Jan;141(1):51-6; discussion 56.

PMID:
16415411
4.

BRCA2 germline mutations in familial pancreatic carcinoma.

Hahn SA, Greenhalf B, Ellis I, Sina-Frey M, Rieder H, Korte B, Gerdes B, Kress R, Ziegler A, Raeburn JA, Campra D, Grützmann R, Rehder H, Rothmund M, Schmiegel W, Neoptolemos JP, Bartsch DK.

J Natl Cancer Inst. 2003 Feb 5;95(3):214-21.

PMID:
12569143
6.

Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas.

Riall TS, Stager VM, Nealon WH, Townsend CM Jr, Kuo YF, Goodwin JS, Freeman JL.

J Am Coll Surg. 2007 May;204(5):803-13; discussion 813-4. Epub 2007 Mar 23.

PMID:
17481488
7.

Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development.

Eguchi H, Ishikawa O, Ohigashi H, Tomimaru Y, Sasaki Y, Yamada T, Tsukuma H, Nakaizumi A, Imaoka S.

Surgery. 2006 Jun;139(6):749-54.

PMID:
16782429
8.

Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm.

Malleo G, Marchegiani G, Borin A, Capelli P, Accordini F, Butturini G, Pederzoli P, Bassi C, Salvia R.

Ann Surg. 2015 May;261(5):984-90. doi: 10.1097/SLA.0000000000000884.

PMID:
25493361
9.

Hereditary intraductal papillary mucinous neoplasm of the pancreas.

Denost Q, Chafai N, Arrive L, Mourra N, Paye F.

Clin Res Hepatol Gastroenterol. 2012 Apr;36(2):e23-5. doi: 10.1016/j.clinre.2011.11.013. Epub 2012 Jan 4.

PMID:
22225963
10.

High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions.

Lucas AL, Shakya R, Lipsyc MD, Mitchel EB, Kumar S, Hwang C, Deng L, Devoe C, Chabot JA, Szabolcs M, Ludwig T, Chung WK, Frucht H.

Clin Cancer Res. 2013 Jul 1;19(13):3396-403. doi: 10.1158/1078-0432.CCR-12-3020. Epub 2013 May 8.

11.

Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.

Waters JA, Schnelldorfer T, Aguilar-Saavedra JR, Chen JH, Yiannoutsos CT, Lillemoe KD, Farnell MB, Sarr MG, Schmidt CM.

J Am Coll Surg. 2011 Aug;213(2):275-83. doi: 10.1016/j.jamcollsurg.2011.04.003. Epub 2011 May 20.

PMID:
21601488
12.

Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas.

Ishida M, Egawa S, Kawaguchi K, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Katayose Y, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T.

Pancreatology. 2008;8(6):577-82. doi: 10.1159/000159844. Epub 2008 Sep 29.

PMID:
18824881
13.

BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing.

Rubin SC, Blackwood MA, Bandera C, Behbakht K, Benjamin I, Rebbeck TR, Boyd J.

Am J Obstet Gynecol. 1998 Apr;178(4):670-7.

PMID:
9579428
14.

Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.

Martin ST, Matsubayashi H, Rogers CD, Philips J, Couch FJ, Brune K, Yeo CJ, Kern SE, Hruban RH, Goggins M.

Oncogene. 2005 May 19;24(22):3652-6.

PMID:
15806175
15.

Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic.

Brooks GA, Stopfer JE, Erlichman J, Davidson R, Nathanson KL, Domchek SM.

Cancer Biol Ther. 2006 Sep;5(9):1098-102. Epub 2006 Sep 11.

PMID:
16931905
16.

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.

Slater EP, Langer P, Fendrich V, Habbe N, Chaloupka B, Matthäi E, Sina M, Hahn SA, Bartsch DK.

Fam Cancer. 2010 Sep;9(3):335-43. doi: 10.1007/s10689-010-9329-6.

PMID:
20195775
17.

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.

Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE.

Cancer Res. 1996 Dec 1;56(23):5360-4.

18.

Pancreatic and extrapancreatic lesions in patients with intraductal papillary mucinous neoplasms of the pancreas: a single-centre experience.

Calculli L, Pezzilli R, Brindisi C, Morabito R, Casadei R, Zompatori M.

Radiol Med. 2010 Apr;115(3):442-52. doi: 10.1007/s11547-010-0502-7. Epub 2010 Jan 15. English, Italian.

PMID:
20082228
19.

Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas.

Larghi A, Panic N, Capurso G, Leoncini E, Arzani D, Salvia R, Del Chiaro M, Frulloni L, Arcidiacono PG, Zerbi A, Manta R, Fabbri C, Ventrucci M, Tarantino I, Piciucchi M, Carnuccio A, Boggi U, Costamagna G, Delle Fave G, Pezzilli R, Bassi C, Bulajic M, Ricciardi W, Boccia S.

Ann Oncol. 2013 Jul;24(7):1907-11. doi: 10.1093/annonc/mdt184. Epub 2013 May 14.

PMID:
23676419
20.

Incidence of extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasms of the pancreas.

Kawakubo K, Tada M, Isayama H, Sasahira N, Nakai Y, Yamamoto K, Kogure H, Sasaki T, Hirano K, Ijichi H, Tateishi K, Yoshida H, Koike K.

Gut. 2011 Sep;60(9):1249-53. doi: 10.1136/gut.2010.227306. Epub 2011 Mar 12.

PMID:
21398676

Supplemental Content

Support Center